Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
      3.00p
  • 52 Week High: 17.50p
  • 52 Week Low: 2.95p
  • Currency: UK Pounds
  • Shares Issued: 113.66m
  • Volume: 0
  • RiskGrade: 464

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -90.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 8.7 n/a
Pr/Book 25.5  
Latest F'cast
Revenue 73.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FAB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-21 4.16 (1.26) (0.12)p n/a n/a n/a n/a 0.0%
31-Mar-22 4.80 (1.33) (4.60)p n/a n/a n/a n/a 0.0%
31-Mar-23 2.90 (2.86) (10.00)p n/a n/a n/a n/a 0.0%
31-Mar-24 1.14 (2.29) (3.90)p n/a n/a n/a n/a 0.0%
31-Mar-25 1.97 (1.78) (1.80)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

FAB Company Announcements

Final Results 04-Sep-2025 07:00 RNS
Contract Win 28-Aug-2025 07:00 RNS
Contract wins with existing client 27-Aug-2025 07:00 RNS

FAB ShareCast News

Fusion Antibodies selected for follow-on projects 27-Aug-2025 ShareCast
Fusion Antibodies validation project with US NIC... 31-Jan-2025 ShareCast
Fusion Antibodies reports positive recent trading 08-Oct-2024 ShareCast

Latest FAB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

FAB Market Data

Currency UK Pounds
Share Price 17.00p
Closing Price Change 3.00p
% Change 0.00 %
52 Week High 17.50p
52 Week Low 2.95p
Volume 0
Shares Issued 113.66m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
Price Trend
96.67% above the market average96.67% above the market average96.67% above the market average96.67% above the market average96.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
26.15% below the market average26.15% below the market average26.15% below the market average26.15% below the market average26.15% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

FAB Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page